LifeStance Health Group, Inc. provided earnings guidance for the third quarter of 2023. For the third quarter of 2023, the company expects total revenue of $250 million to $260 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.475 USD | -0.64% | -4.96% | -30.20% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.20% | 210.64Cr | |
+21.79% | 8.71TCr | |
-24.57% | 7.56TCr | |
+1.76% | 2.68TCr | |
+3.99% | 1.79TCr | |
-15.03% | 1.64TCr | |
+2.07% | 1.57TCr | |
+69.03% | 1.33TCr | |
+75.56% | 1.31TCr | |
+3.11% | 1.25TCr |
- Stock Market
- Equities
- LFST Stock
- News LifeStance Health Group, Inc.
- LifeStance Health Group, Inc. Provides Earnings Guidance for the Third Quarter of 2023